Brune; Michael E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brune; Michael E..The latest application filed is for "inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme".

Company Profile

0.15.19

Brune; Michael E. - Mundelein IL
Brune, Michael E - Mundelein IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment of central nervous system disorders Grant 9,464,072 - Bitner , et al. October 11, 2	2016-10-11
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 9,290,444 - Bitner , et al. March 22, 2	2016-03-22
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20150265613 - Bitner; R. Scott ; et al.	2015-09-24
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 9,133,145 - Bitner , et al. September 15, 2	2015-09-15
Treatment Of Central Nervous System Disorders App 20150099740 - Bitner; R. Scott ; et al.	2015-04-09
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,993,632 - Bitner , et al. March 31, 2	2015-03-31
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20150065508 - Bitner; R. Scott ; et al.	2015-03-05
Treatment of central nervous system disorders Grant 8,940,902 - Bitner , et al. January 27, 2	2015-01-27
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,716,345 - Bitner , et al. May 6, 2	2014-05-06
Methods Of Use Of Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20130338169 - Bitner; R. Scott ; et al.	2013-12-19
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,415,354 - Bitner , et al. April 9, 2	2013-04-09
Treatment Of Central Nervous System Disorders App 20130059829 - Bitner; R. Scott ; et al.	2013-03-07
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20130045978 - Bitner; R. Scott ; et al.	2013-02-21
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20120289512 - Bitner; R. Scott ; et al.	2012-11-15
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 8,198,331 - Bitner , et al. June 12, 2	2012-06-12
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,855,308 - Brune , et al. December 21, 2	2010-12-21
Treatment Of Central Nervous System Disorders App 20100152179 - Bitner; R. Scott ; et al.	2010-06-17
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Grant 7,737,137 - Brune , et al. June 15, 2	2010-06-15
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090192198 - Bitner; R. Scott ; et al.	2009-07-30
Methods Of Use Of Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090192141 - Bitner; R. Scott ; et al.	2009-07-30
Inhibitors Of The 11-beta-hydroxysteroid Dehydrogenase Type 1 Enzyme App 20090176783 - Bitner; R. Scott ; et al.	2009-07-09
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme App 20090131434 - Brune; Michael E. ; et al.	2009-05-21
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Grant 7,511,175 - Patel , et al. March 31, 2	2009-03-31
Treatment Of Central Nervous System Disorders App 20090054426 - Bitner; R. Scott ; et al.	2009-02-26
Combination and use of drugs App 20060276549 - Jacobson; Peer B. ; et al.	2006-12-07
Use of alpha- 1- alpha adrenoceptor agonists with alpha-1-Beta antagonism for the treatment of stress urinary incontinence App 20020183357 - Brioni, Jorge D. ; et al.	2002-12-05
Use of alpha1A adrenoceptor agonists with alpha1B and alpha1D antagonism for the treatment of stress urinary incontinence App 20010039255 - Brioni, Jorge D. ; et al.	2001-11-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.